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Abstract 
Ten mitochondrial carriers have been purified from animal mitochondria. They are small proteins with a molecular mass ranging from 28 to 34 
kDa on SDS-PAGE. So far, five of these proteins have been sequenced. Their polypeptide chain consists of three tandemly related sequences of about 
100 amino acids. The repeats of the different proteins are related and probably fold into two transmembrane a-helices linked by an extra-membrane 
loop. The features of this family are also present in several proteins of unknown function characterized by DNA sequencing. Isoforms of some carriers 
have been found. All mitochondrial carriers investigated in proteoliposomes function according to a simultaneous (sequential) mechanism of 
transport. The only exception is the carnitine carrier that proceeds via a ping-pong mechanism. Three mitochondrial carriers have been expressed 
in yeast and two overexpressed in E. coli and refolded in active form. 
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1. Introduction 
The transport of metabolites across the inner mito- 
chondrial membrane is catalyzed by specific carrier pro- 
teins that span the lipid bilayer. At present there are at 
least twelve metabolite carriers well characterized in in- 
tact mitochondria [1,2]. The majority of these carriers 
deal with anions (ADP/ATP, Pi, oxoglutarate, aspartate/ 
glutamate, pyruvate, citrate, dicarboxylates, branched 
keto acids and ATP Mg!P,), but some transport cations 
or zwitterions (acylcarnitines/carnitine, ornithine, sper- 
mine and glutamine). The uncoupling protein (UCP) 
from brown fat mitochondria, which is a H+ carrier, 
must also be included among these proteins because of 
the sequence similarity. In addition to these ‘major’ car- 
riers, many others must exist in the inner mitochondrial 
membrane for the import of various nucleotides, cofac- 
tors and compounds which are not synthesized in mito- 
chondria. 
Nearly all the mitochondrial carriers characterized so far 
catalyse the exchange of substrates across the membrane. 
Those mediating H+-compensated unidirectional sub- 
strate flux (PiC, PYC, GC) may also fall into the above 
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category because at least the PiC has been shown to 
function in a phosphate/OH- antiport mode [3]. The 
CAC is the only mitochondrial transporter that catalyzes 
both acylcarnitine/carnitine antiport and substrate 
uniport, whereas for the UCP the uniport mode is the 
exclusive transport mode. 
The carriers involved in oxidative phosphorylation 
(AAC and PiC) are present in all mitochondria. Also the 
main carriers for import of reducing equivalents or sub- 
strates for oxidative phosphorylation in the mitochon- 
drial matrix (PYC, CAC, OGC and AGC) are widely 
distributed. Other carriers, on the other hand, are tissue 
specific and have a limited distribution reflecting their 
importance in special functions, e.g. gluconeogenesis 
(DIC), fatty acid and lipid synthesis (CIC), urea synthe- 
sis (ORC, GC and GNC) or thermogenesis (UCP). Al- 
though characteristic of the inner mitochondrial mem- 
brane, the metabolite carriers are generally present in the 
membrane in very minute amounts. Only the AAC, the 
PiC and the UCP of brown fat represent an important 
share of the mitochondrial protein. As reported below, 
significant advancement in the field of mitochondrial 
metabolite transport systems has been made by elucidat- 
ing an increasing number of primary structures, investi- 
gating the transmembrane topology, purifying and re- 
constituting all the major carriers, elucidating their ki- 
netic mechanism, and expressing some of them in yeast 
and E. coli. 
2. Identification and purification 
Purification and subsequent reconstitution of pure 
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Fig. 1. Alignment of the repetitive lements in the primary structure of the biochemically known mitochondrial carriers sequenced so far. The asterisks 
indicate identities, while highly conservative substitutions are shown by the dots. The sequences shown are the human Tl isoform of AAC [23], the 
human UCP [24], the human PiC [25], the human OGC [26] and the rat CIC [19]. Segments I-VI represent hydrophobic regions that might be folded 
into transmembrane a-helices. The transmembrane s gments are linked by extensive hydrophilic regions (A, B and C) and the three repeats by shorter 
stretches of hydrophilic amino acids (a’ and b’) indicated by the dotted lines. 
protein in artificial membranes is essential for identi&a- 
. _ ._ _ _ 
tion, detailed functional characterization and structural 
studies of a transport protein. So far, 10 carrier proteins 
have been purified to homogeneity from mammalian mi- 
tochondria [1,4]. Table 1 gives an overview of the purifi- 
cation of these carriers. The most striking feature is the 
particular usefulness of hydroxyapatite and celite in 
chromatographic procedures. With very few exceptions, 
all mitochondrial carrier proteins have been purified 
using variations of a general procedure based on hydrox- 
yapatite and celite chromatography. All mitochondrial 
metabolite carriers isolated until now fall into a very 
Table 1 
Purification and reconstitution of mitochondrial carriers 
Carrier Source Solubilization Purified by Mol. wt. 
(SPAGE) 
Identification by References 
1. ADP/ATP BHM TX-100 HA-chrom. 30 kDa Inhib. binding [51 
2. Uncoupling protein BFM TX-100 HA-chrom./ultracentr. 32 kDa GTP-binding 161 
3. Phosphate PHM TX-100 + DPG HAlaffin. chrom. 33 kDa Reconstitution 
4. Oxoglutarate PHM TX-l 14 HAloelite chrom. 31.5 kDa Reconstitution 
5. Dicarboxylate 
t: 
RLM TX-114 HA/celite chrom. 28 kDa Reconstitution 191 
6. Citrate RLM TX-100 + DPG HA/celite chrom. 30 kDa Reconstitution ]lOl 
7. Pyruvate BHM TX-100 HA/afIin. chrom. 34 kDa Reconstitution [ill 
8. Camitine RLM TX-100 HAloelite chrom. 32.5 kDa Reconstitution 
9. Aspartate&lutamate 
U21 
BHM &Es HNcelite chrom. 31.5 kDa Reconstitution 
10. Ornithine 
1131 
RLM TX-100 HA-chrom. and others 33.5 kDa Reconstitution ]141 
Only the first publications reporting complete purification are mentioned. Abbreviations for different sources of mitochondria re: BHM, beef heart; 
BLM, beef liver; RLM rat liver; PHM, pig heart; BFM, brown fat. Other abbreviations: C&E,, octa-ethyleneglycohnono-n-dodecyl ther; DPG, 
cardiolipin; HA, hydroxyapatite; SPAGE, SDS-polyacrylamide gel electrophoresis. 
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narrow range of apparent molecular masses between 28 
and 34 kDa (Table 1). 
3. Primary structures and extension of the carrier family 
The amino acid sequences of 5 mitochondrial carriers 
that have been biochemically characterized, namely 
AAC, UCP, PiC, OGC and CIC, have been determined 
by amino acid analysis or DNA sequencing [15-l 93. The 
first primary structure of AAC from bovine heart was 
determined in 1982. During the last 10 years, AAC has 
been sequenced from 13 organisms (20 sequences includ- 
ing isoforms), UCP from 6, PiC from 5 (7 sequences 
including isoforms) and OGC from 4 species (see [20,21] 
for references, and [22]). Comparison of the amino acid 
sequences of the mitochondrial carriers with themselves 
has shown that they have a tripartite structure, made up 
of related sequences about 100 amino acids in length 
(Fig. 1). Each repetitive element contains 2 hydrophobic 
stretches (I-VI) separated by an extensive hydrophilic 
region (A-C), and the repeats of one carrier are related 
to those present in the others. 
The alignment of 15 sequences of five functionally 
characterized carriers (Fig. 1) shows that 14 residues are 
totally conserved and 30 are substituted in a highly con- 
Table 2 
Kinetic data of purified and reconstituted mitochondrial carrier proteins* 
servative manner. A distinct feature is the sequence motif 
P-h-D/E-h-h-K/R-h-R/K-(20-30 amino acids)-D/E-G- 
(4 amino acids)-a-K/R-G (h = hydrophobic, a = aro- 
matic) which is present in many repeated domains. Al- 
though the number of conserved amino acids is relatively 
low, the tripartite structure, the presence of the two hy- 
drophobic regions in each domain and the three-fold 
repetition of the sequence motif show that these five 
mitochondrial carriers belong to the same protein family. 
Their structure originates from a common ancestor by 
two-tandem gene duplication. 
The characteristic sequence features of the mitochon- 
drial carrier family have been used to identify other 
proteins of unknown function as members of the same 
family, such as MRS3 and MRS4 from S. cerevisiue 
(probably isoforms of the same protein), a protein asso- 
ciated with Grave’s disease, a protein from the ciliated 
protozoa Oxytricia fallax, two proteins encoded by 
genes in chromosomes IX and XI from S. cerevisiae, and 
four proteins of the nematode Caenorhabditis elegans 
(see [20] for references). Recently, two other members of 
the mitochondrial metabolite carrier family, namely the 
maize brittle1 protein [27] and the PMP47 from Candidu 
. . . . 
bozdznzz [28] have been identified in amyloplasts and per- 
oxisomes, respectively, indicating that metabolite carrier 
proteins of this type are not restricted to mitochondria 
Carrier Substrate K, (mM) L (mM) &ax Activation Kinetic 
external internal (mmohmin x g) energy mechanism 
AAC ATP 0.01 
ADP 0.01 
PiC Pi/Pi 
P,/OH- 
OGC Oxoglutarate 
Malate 
DIC Malate 
Malonate 
Phosphate 
CIC Citrate 
Malate 
AGC Aspartate 
Glutamate 
1.8 fO.l 
0.31 f 0.08 
1.36 f0.14 
0.49 f 0.05 
0.54 f 0.10 
1.41 + 0.35 
0.032 + 0.004 
0.25 f 0.03 
0.12 f 0.02 
0.25 
CAC 
ORC 
PYC 
Camitine (exchange) 1.1 + 0.1 
Camitine (uniport) 0.53 + 0.12 
Omithine 0.16 + 0.02 
Pyruvate 0.24 + 0.02 - 
0.025 up to 7.1 160162 nd. 
9.4 f 0.1 
11.2 f0.9 
0.17 + 0.06 
0.71 kO.18 
0.92 f 0.16 
n.d. 
0.93 f 0.18 
0.027 f 0.004 
0.060 f 0.006 
2.8 k 0.6 
3 
92 
53 
64 Simultaneous 
Simultaneous 
9.5 f 1.5 
10.0 f 1.1 
54 Simultaneous 
Simultaneous 
6.0 f 1.6 
5.9 + 0.9 
6.0 + 1.4 
96 Simultaneous 
n.d. 
10.5 f 1.9 
11.5 f 1.8 
70 
Simultaneous 
n.d.** 77 
10 + 0.8 
2.2 f 0.4 
4 
1.7 f 1.3 
0.2 f 0.09 
133 
115 
ping-pong 
3.2 + 0.7 89 nd. 
n.d. 114 f21 n.d. n.d. 
* All data are from studies using hydrophobic chromatography for reconstitution except those for the AAC (see [4] and [43] for references and [3,44]). 
** V,,,,, value has not been determined with the purified protein (see [13]). 
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but represent a more extended family in eukaryotes. In- 
cluding these new members, there are at present 16 dif- 
ferent members of this protein family. 
4. Secondary structure and transmembrane topology 
The two hydrophobic stretches present in each of the 
three repeats are sufficiently long to span the membrane 
as a-helices. On the basis of the tripartite structure and 
the hydrophobic profile of AAC, Saraste and Walker 
[29] proposed that each repetitive domain consists of two 
transmembrane a-helices forming a structure with, in 
total, six a-helices (I-VI). The two helices of the individ- 
ual elements are linked by an extensive, more polar seg- 
ment (A, B and C), whereas the three repeats are con- 
nected by shorter stretches of hydrophilic amino acids (a’ 
and b’) (see Fig. 1). The essential predictions of this 
model are: the N- and C-termini of the polypeptide chain 
are exposed to the same side of the membrane, the three 
long hydrophilic segments connecting the two a-helices 
of each domain (A, B and C) are located on one side of 
the membrane (opposite to that of the N- and C-termini), 
and the two shorter hydrophilic segments a’ and b’ on the 
other side. 
Many of these features have been demonstrated by 
investigating the accessibility of extra-membranous re- 
gions of various carriers to impermeable reagents such 
as peptide-specific antibodies and proteolytic enzymes. 
In the case of PiC, the N- and C- terminal regions as well 
as loops a’ and b’ are exposed to the cytoplasmic side of 
the inner mitochondrial membrane, whereas loop B is 
exposed to the matrix side [30]. Similarly, in the case of 
UCP, the N- and C-termini and loop a’ are oriented 
towards the cytosol, whereas loops A, B and C are ori- 
ented towards the matrix [31,32]. It was also shown that 
the N-terminal region of the AAC is exposed on the 
cytosolic side of the membrane [33], and when the carrier 
is conformationally stabilized by the inhibitor bongkre- 
kit acid, the postulated loops A, B and C are accessible 
to proteases on the matrix side [34]. 
Recent topological data concerning OGC are also in 
agreement with the six cc-helix model proposed by Sar- 
aste and Walker. Also in this case, the cytoplasmic expo- 
sure of both N- and C-terminal sequences was demon- 
strated, and furthermore loops A and B were shown to 
protrude into the matrix and loop a’ to be exposed to- 
wards the cytosol [30,35]. It is possible that during the 
conformational change occurring in the transport proc- 
ess one or more of the loops A, B and C might be inserted 
into the lipid bilayer as hairpin structures. It was shown 
that the segments of the polypeptide chain of AAC span- 
ning residues F153-M200 and Y25O-M281 (belonging 
to the matrix loops B and C in the model) are covalently 
labelled by two non-permeant specific ligands, azido 
atractyloside and azido [a-32P]ADP, respectively, when 
these are added from the cytoplasmic side of the mem- 
brane [21]. Similarly, loop C of UCP was shown to be 
photolabelled by 2-azido ADP [36] and loop A of PiC to 
react, at the level of Cys-41 (rat liver PiC), with the 
impermeable osin maleimide [37]. 
5. Genes and organ specificity 
The sequences of the genes of AAC, UCP, OGC and 
PiC have been determined during the last years [22- 
24,26,38,39]. The structures of these genes are related, 
containing the introns in equivalent positions. For exam- 
ple, they all contain an intron after the first and before 
the sixth transmembrane segment. In this respect there 
is a tendency for the introns to interrupt the coding 
sequence in or near the extra-membrane loops. 
Some mitochondrial carriers have isoforms encoded 
by different genes (see [20] for references, and [40,41]). 
The three human genes for AAC are expressed in heart, 
liver and fibroblasts, respectively. Only one gene, on the 
other hand, has been found for UCP and OGC. Al- 
though only one gene exists for PiC, two different tran- 
scripts have been characterized in man, cow [22] and rat 
(V. Iacobazzi and F. Palmieri, unpublished results). 
These arise from alternative splicing affecting amino 
acids 445 of the mature PiC protein [22]. One form is 
expressed most strongly in heart and liver, and the other 
in lung. The functional difference of the expressed 
isoforms in different mammalian tissues is not yet 
known. For the yeast AACl and AAC2 isoforms, it has 
been found that the transport activity of the former is 
40% of that of the latter [42]. 
6. Functional studies 
For functional characterization in terms of transport 
activity, the purified carrier proteins are reconstituted 
into liposomes. For eight purified and reconstituted car- 
riers, a complete set of kinetic data, including substrate 
specificity, affinity, number of binding sites, interaction 
with inhibitors, activation energy, influence of pH and 
of phospholipids, has been obtained [4]. In particular, K,,, 
values have been determined not only on the external 
side (as generally carried out in mitochondria) but also 
on the internal side of the proteoliposomes. Some of 
these data are summarized in Table 2. Importantly, for 
at least one substrate of each carrier, the apparent Km on 
the inside is significantly different from that on the out- 
side. Furthermore, except for AAC, no significant 
amount of the carrier population with ‘internal Km' was 
found on the outside and vice versa. Most carriers are, 
therefore, unidirectionally inserted into the liposomal 
membrane. By comparing the internal and the external 
transport affinities determined in proteoliposomes with 
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the values measured in intact mitochondria, it has been 
concluded that AGC, CIC, DIC, CAC and PiC are ori- 
ented right-side-out, as in intact mitochondria, whereas 
the OGC is inserted in the opposite direction (see [4] for 
references). 
The asymmetric orientation of the membrane-embed- 
ded carrier proteins, and the independence of the ex- 
change reactions from the type of counter-substrate have 
provided well-defined conditions for studying the trans- 
port mechanisms of the reconstituted mitochondrial car- 
riers using a kinetic approach. Two-substrate initial ve- 
locity studies showed that the reconstituted AGC, OGC, 
CIC, DIC and PiC function according to a simultaneous 
(sequential) mechanism, implying that one internal and 
one external substrate molecule form a ternary complex 
with the carrier before transport occurs (see [4]). A se- 
quential mechanism has also been shown for OGC and 
AGC by studies with intact mitochondria [45,46]. 
On this basis it has been proposed that the mitochon- 
drial carriers not only form a structural family but also 
constitute a homogeneous functional family character- 
ized by a common kinetic mechanism [l]. Surprisingly, 
it was recently found that CAC proceeds via a ping-pong 
mechanism [47], indicating that only one binding site 
exists which is alternately exposed to each side of the 
membrane. The CAC is the only mitochondrial translo- 
cator mediating both exchange and uniport. Presumably 
‘re-orientation’ or conformational change of the un- 
loaded carrier can be achieved more easily when only 
binary complexes, and not ternary complexes, are in- 
volved in the catalytic cycle. The knowledge of the pri- 
mary structure of CAC will obviously be needed to an- 
swer whether this carrier belongs to the mitochondrial 
carrier family. However, it should be pointed out that the 
presence of both the ping-pong and simultaneous mecha- 
nisms within the same structural family has been ob- 
served before, for example in the family of proteins re- 
lated to the erythrocyte anion carrier. Apart from this 
problem, it should be recalled that the well-documented 
existence of two conformational states of AAC, depend- 
ing on the side at which the ligands are bound, has been 
interpreted in terms of re-orientation of the ligand bind- 
ing site [48]. These findings may be explained by assum- 
ing a functional dimer (or tetramer) composed of two 
monomers with one substrate binding site and one trans- 
port channel each [1,4]. 
By reaction of particular cysteine residues with mercu- 
rial reagents, several carriers could be reversibly con- 
verted to a functional state different from the various 
physiological transport modes [ 1,4,49]. This ‘unphysio- 
logical’ transport mode is characterized by a complete 
inhibition of the ‘physiological’ transport functions and 
by a unidirectional substrate flux with a more or less 
complete loss of substrate specificity. The new type of 
activity can be interpreted to indicate the presence of an 
intrinsic unspecific hannel within the mitochondrial car- 
tier proteins, which is normally hidden by appropriate 
gates. This interpretation may be reconciled with the 
emerging eneral concept of the evolution of carrier pro- 
teins, starting from simple pores and evolving gradually 
to more and more complex structures. 
7. Expression and site-directed mutagenesis 
Despite some previous attemps [50], over-expression 
of intact mitochondrial carriers in bacteria in the func- 
tionally active state has been accomplished only recently. 
Fiermonte et al. [5 l] succeeded in expressing in E. coli the 
full-length bovine OGC at a level of about 15 mg/l of 
culture and the full-length bovine AAC at somewhat 
lower levels. Both OGC and AAC accumulated as insol- 
uble inclusion bodies in the bacterium. OGC was solubil- 
ized with sarcosyl and reconstituted into liposomes. The 
transport properties of this reconstituted carrier were 
shown to be the same as those determined for the native 
OGC in mitochondria. This is the first time that a eukar- 
yotic membrane protein has been over-expressed in E. 
coli and renatured. Since the bovine PiC has also been 
over-expressed in E. coli and refolded into the reconstitu- 
tively active form (G. Fiermonte, personal communica- 
tion), it is possible that also the other mitochondrial 
carriers may be expressed with the vector used for the 
expression of the OGC and AAC. 
Site-directed mutagenesis tudies of AAC and PiC 
have been performed so far only in yeast, where expres- 
sion of these proteins was accomplished before this was 
done in E. coli. In the yeast AAC2 essential residues were 
found to be the three arginines which are located within 
the transmembrane helices and possibly within the 
translocation channel, the triplet R252-254 which is lo- 
cated on the matrix side within the third hydrophilic loop 
and possibly participating in an annular positive field 
around the channel entrance, and the only lysine (K39) 
which is located within a transmembrane helix probably 
involved in substrate binding and translocation [32,52]. 
Mutation of T43 to C of the yeast PiC resulted in 90% 
inhibition, suggesting that this residue (corresponding to 
C42 in the bovine heart PiC or C41 in the rat liver PiC) 
plays an important role in the Pi transport mechanism 
]531. 
8. Biogenesis and import into mitochondria 
Mitochondrial carriers are products of nuclear genes 
and have to be imported into the mitochondrial inner 
membrane. AAC, UCP, OGC and the yeast PiC are 
synthesized without a targeting presequence, whereas the 
mammalian PiC and CiC carry cleavable presequences 
of different lengths. The import of AAC, UCP and PiC 
uses the general mitochondrial import pathway [5456]. 
E PalmierilFEBS Letters 346 (1994) 48-54 
Thus, it requires cytosolic factors, ATP and a membrane 
potential. Differently from most other mitochondrial 
proteins, the AAC and the PiC preferentially use the 
special receptor, MOM72, of the outer membrane as 
their main import receptor [54,57]. Furthermore, AAC 
and UCP are probably inserted directly into the inner 
membrane without first passing through the matrix, i.e. 
they are imported into the mitochondria through a non- 
conservative pathway [54,58]. It has also been shown 
that effective import of AAC and UCP depends on par- 
ticular regions within their mature sequence [54]. 
The role of the cleavable presequence of the mammal- 
ian PiC has been studied by two groups [56,59]. It ap- 
pears that the major import information must reside in 
the mature part of the PiC, as in the case of the other 
presequence-deficient members of the mitochondrial car- 
rier family. Recently, it has been proposed that the yeast 
PiC/p32 functions as an import receptor on the outer 
mitochondrial membrane [60]. However, the submito- 
chondrial localization and the mechanism of import [57], 
as well as the functional expression in a yeast strain 
deficient in endogenous PiC [53], characterize the yeast 
PiC/p32 as a member of the mitochondrial inner mem- 
brane carrier family. 
9. Conclusions 
Although definite progress in the study of the mito- 
chondrial carrier proteins at molecular level has been 
made in the last few years, we have to admit that the 
catalytic mechanism of metabolite translocation is not 
yet known. Several models describing transport mecha- 
nisms have been published [4,32], but it is clear that the 
basic mechanisms of metabolite transport in the case of 
the mitochondrial carriers or in any other fields of mem- 
brane biology will not be understood until the three- 
dimensional structures of the catalysts become accessi- 
ble. Crystallization of the mitochondrial carrier proteins 
may be at hand now that functional over-expression of 
these transport proteins has been achieved. 
Achowledgemenfs: The research in the author’s laboratory was sup- 
ported by grants from the CNR Target Project ‘Ingegneria Genetica’ 
and from Telethon, Italy (Grant 362). 
References 
111 
121 
[31 
r41 
151 
Kramer, R. and Pahnieri, F. (1992) in: Molecular Mechanisms in 
Bioenergetics (Emster, L., ed.) pp. 359-384, Elsevier, Amsterdam. 
Walker, J.E. (1992) Cum Opin. Struct. Biol. 2, 519-526. 
Stappen, R. and Kramer, R. (1994) J. Biol. Chem. (in press). 
Pahnieri, F., Indiveri, C., Bisaccia, F. and Kramer, R. (1993) J. 
Bioenerg. Biomembr. 25, 525-535. 
Riccio, P, Aquila, H. and Klingenberg, M. (1975) FEBS Lett. 56, 
133-138. 
El Lin, C.S. and Klingenberg, M. (1980) FEBS I&t. 113, 299-303. 
53 
[7j De Pinto, V., Tommasino, M., Pahnieri, F. and Kadenbach, B. 
(1982) FEBS Lett. 148. 103-106. 
VI 
[91 
DO1 
1111 
WI 
[I31 
1141 
P51 
WI 
P71 
WI 
P91 
PO1 
WI 
[221 
Bisaccia, F., Indiveri, C. and Pahnieri, F. (1985) Biochim. Biophys. 
Acta 810, 362-369. 
. , 
Bisaccia, F., Indiveri, C. and Pahnieri, F. (1988) Biochim. Biophys. 
Acta 933, 229-240. 
Bisaccia, F., De Palma, A. and Palmieri, F. (1989) Biochim. Bio- 
phys. Acta 971, 171-176. 
Bolli, R., Nalecz, K.A. and Azzi, A. (1989) J. Biol. Chem. 264, 
18024-18030. 
Indiveri, C., Tonazzi, A. and Palmieri, F. (1990) Biochim. Biophys. 
Acta 1020, 81-86. 
Bisaccia, F., De Pahna, A. and Pahnieri, E(1992) Biochim. Bio- 
phys. Acta 1106, 291-296. 
Indiveri, C., Tonazzi, A. and Palmieri, F. (1992) Eur. J. B&hem. 
207, 449454. 
Aquila H., Misra, D., Eulitz, M. and Klingenberg, M. (1982) 
Hoppe Seyler’s Z. Physiol. Chem. 363, 345-349. 
Aquila, H., Link, T.A. and Klingenberg, M. (1985) EMBO J. 4, 
2369-2376. 
Runswick, M.J., Powell, S.J., Nyren, P. and Walker, J.E. (1987) 
EMBO J. 6, 1367-1373. 
Runswick, M.J., Walker, J.E., Bisaccia, F., Iacobazzi, V. and 
Pahnieri, F. (1990) Biochemistry 29, 11033- 11040. 
Kaplan, R.S., Mayor, J.A. and Wood, D.O. (1993) J. Biol. Chem. 
268, 13682-13690. 
Walker, J.E. and Runswick, M.J. (1993) J. Bioenerg. Biomembr. 
25, 435446. 
Brandolin, G., Le Saux A., Trezeguet, V., Lauquin, G.J.M. and 
Vignais, P.V. (1993) J. Bioenerg. Biomembr. 25, 459-472. 
Dolce, V., Iacobazzi, V., Pahnieri, F. and Walker, E.J. (1994) J. 
Biol. Chem. 269, 10451-10460. 
[23] Cozens, A.L., Runswick, M.J. and Walker, J.E. (1989) J. Mol. 
Biol. 206, 261-280. 
[24] Cassard, A.M., Bouillard, F., Mattei, M.G., Hentz, E., Raimbault, 
S., Thomas, M. and Ricquier, D. (1990) J. Cell. B&hem. 43, 
255-264. 
[25] Dolce, V., Fiermonte, G., Messina, A. and Palmieri, F. (1991) 
DNA Sequence 2, 131-134. 
[26] Iacobazzi, V., Pahnieri, F., Runswick, M.J. and Walker, J.E. 
(1992) DNA Sequence 3, 79-88. 
[271 Sullivan T.D., Strelow, L.I., Illingworth, C.A., Phillips, R.L. and 
Nelson Jr., O.E. (1991) Plant Cell 3, 1337-1348. 
[28] Jank, B., Habermann, B., Schweyen, R.J. and Link, T.A. (1993) 
Trends Biochem. Sci. 18, 427-428. 
[29] Saraste, M. and Walker, J.E. (1982) FEBS Lett. 144, 250-254. 
[30] Pahnieri, F., Bisaccia, F., Capobianco, L., Dolce, V., Fiermonte, 
G., Iacobazzi, V and Zara, V. (1993) J. Bioenerg. Biomembr. 25, 
493-50 1. 
[31] Miroux, B., Froscard, V., Raimbault, S., Ricquier, D. and 
Bouillaud, F. (1993) EMBO J. 12, 3739-3745. 
[32] Klingenberg, M. (1993) J. Bioenerg. Biomembr. 25, 447-457. 
[33] Brandolin, G., Boulay, F., Dalbon, P and Vignais, PV (1989) 
Biochemistry 28, 1093-l 100. 
[34] Marty, I., Brandolin, G. and Vignais, P.V (1991) Biochemistry 31, 
40584065. 
[35] Bisaccia, F., Capobianco, L., Brandolin, G. and Pahnieri, F. 
(1994) Biochemistry 33, 3705-3713. 
[36] Winkler, E. and Klingenberg, M. (1992) Eur. J. B&hem. 203, 
295-304. 
[371 Ferreira, G. C. and Pedersen, P.L. (1993) J. Bioenerg. Biomembr. 
25, 483492. 
[38] Li, K., Warner, C., Hodge, J. A., Minoshima, S., Kudoh, J., 
Fukuyama, R., Maekawa, M., Shimizu,Y, Shim&u, N. and 
Wallace, D.C. (1989) J. Biol. Chem. 264, 13998-14004. 
[39] Kozak, L.P, B&ton, J.H., Kozak, U.C., Wells, J.M. (1988) J. 
Biol. Chem. 263, 1227412277. 
54 E PalmierilFEBS Letters 346 (1994) 48-54 
[40] Kaplan, R.S. and Mayor, J.A. (1993) J. Bioenerg. Biomembr. 25, 
503-514. 
[41] Azzi, A., Glerum, M., Koller, R., Mertens, W. and Spycher, S. 
(1993) J. Bioenerg. Biomembr. 25, 515-524. 
[42] Gawaz, M., Douglas M.G. and Klingenberg M. (1990) J. Biol. 
Chem. 265, 14202-14208. 
[43] Kramer, R. and Palmieri, F. (1989) Biochim. Biophys. Acta 974, 
l-23. 
[44] Nalecz, K.A., Kaminska, J., Nalecz, M.J. and Azzi, A. (1992) 
Arch. Biochem. Biophys. 297, 162-168. 
[45] Sluse, F.E., Duyckaerts, C., Liebecq, S. and Sluse-Goffart, M. 
(1979) Eur. J. Biochem. 100, 3-17. 
[46] Sluse, F.E., Evens, A., Dierks, T., Duyckaerts, C., Sluse-Goffart, 
C.M. and Kramer, R. (1991) Biochim. Biophys. Acta 1058, 329- 
338. 
[47] Indiveri, C., Tonazzi, A. and Palmieri, F. (1994) Biochim. Biophys. 
Acta 1189, 65-73. 
[48] Klingenberg, M. (1989) Arch. B&hem. Biophys. 270, 1-14 
[49] Dierks, T., Salentin, A. and Kramer, R. (1990) Biochim. Biophys. 
Acta 1028, 281-288. 
[50] Ferreira, G. C. and Pedersen, P.L. (1992) J. Biol. Chem. 267, 
5460-5466. 
[51] Fiermonte, G., Walker, J.E. and Palmieri, F. (1993) B&hem. J. 
294, 293-299. 
[52] Nelson, D.R. and Douglas, G. (1993) J. Mol. Biol. 230, 1171- 
1182. 
[53] Phelps, A. and Wohlrab, H. (1991) J. Biol. Chem. 266, 19882- 
19885. 
[54] Pfanner, N. and Neupert, W. (1990) Annu. Rev. Biochem. 59, 
331-353. 
[55] Zara, V., Rassow, J., Wachter, E., Tropschug, M., Palmieri, F., 
Neupert, W. and Pfanner, N. (1991) Eur. J. Biochem. 198, 405- 
410. 
[56] Pratt, R.D., Ferreira, G.C. and Pedersen, P.L. (1991) J. Biol. 
Chem. 266, 12761280. 
[57] Dietmeier, K., Zara, V., Palmisano, A., Pahnieri, F., Voos, W., 
Schlossmann, J., Moczko, M., Kispal, G. and Pfanner, N. (1993) 
J. Biol. Chem. 268, 25958-25964. 
[58] Glick, B.S., Beasley, E.M. and Schatz, G. (1992) Trends Biochem. 
Sci. 17, 453459. 
[59] Zara, V., Palmieri, F., Mahlke, K. and Pfanner, N. (1992) J. Biol. 
Chem. 267, 12077-12081. 
[60] Pain, D., Murakami, H. and Blobel, G. (1990) Nature 347, 444 
449. 
